Professor Tomasz Burzykowski to join IDDI
This article was originally published in Scrip
IDDI (International Drug Development Institute), a company with headquarters in Belgium and offices in Paris, France, and Cambridge, Massachusetts, has named Professor Tomasz Burzykowski director of research. He will keep his academic position at the University of Hasselt, Belgium, and a visiting position at the Karolinska Institute in Stockholm, Sweden. IDDI offers statistical methodology and innovative web systems for the design and conduct of clinical trials.
You may also be interested in...
The US FDA issued only one device-related close-out letter in October.
Seven pharmacies have filed a lawsuit against the FDA claiming the agency exceeded its statutory authority in its final standard memorandum of understanding on interstate compounding and that the MOU will have an adverse impact on compounding pharmacies and patients.
Several experts spoke with Scrip about their take on how the biopharmaceutical industry's efforts to respond to COVID-19 might help industry's image problem.